Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Journal of Environmental Management|March 14, 2018
Sediment exchange to mitigate pollutant exposure in urban soilDaniel Walsh, Katherine Glass, Samantha Morris, et al.
Blood|December 1, 2010
CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemiaMariela Sivina, Elena Hartmann, Thomas J Kipps, et al.
Journal for Immunotherapy of Cancer|November 20, 2021
Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067Meredith M Regan, Charlene M Mantia, Lillian Werner, et al.
Clinical Genitourinary Cancer|February 10, 2015
GermLine Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes After Radiation Therapy for Prostate Cancer: Results of a Test and Validation Set AnalysisDanielle N Margalit, Kristina M Jordahl, Lillian Werner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2011
Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemiaPhilip C Amrein, Eyal C Attar, Tak Takvorian, et al.
European Journal of Nutrition|January 24, 2022
Dietary patterns and cognitive function in older New Zealand adults: the REACH studyKaren D Mumme, Cathryn A Conlon, Pamela R von Hurst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local TherapyRana R McKay, Amado J Zurita, Lillian Werner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2019
Treatment-Free Survival: A Novel Outcome Measure of the Effects of Immune Checkpoint Inhibition-A Pooled Analysis of Patients With Advanced MelanomaMeredith M Regan, Lillian Werner, Sumati Rao, et al.
Pageof 17